期刊文献+

益气化瘀方干预下肢动脉病变腔内治疗后急性血栓形成临床分析 被引量:1

下载PDF
导出
摘要 目的:观察益气化瘀方干预下肢动脉病变腔内治疗后急性血栓形成的临床疗效。方法:36例均用益气化瘀方干预。观察临床疗效及干预前后肢围、血液流变学变化。结果:痊愈19例,显效11例,有效5例,无效1例,总有效率97.22%。干预后患肢踝周径、胫周径和股周径较干预前均有明显减小(P<0.05),血沉、全血高切黏度和全血还原高切黏度等血液流变学指标均有明显下降(P<0.05)。结论:益气化瘀方干预下肢动脉病变腔内治疗后急性血栓形成能够提高治愈率,改善血液流变学指标,安全有效。 Objective: To investigate the clinical eifficacy YQHYR intervention alter enaovascutar treatment of acute lower extremity arterial disease thrombosis.Methods: June 2011 to May 2013 in our hospital after endovascular treatment of lower extremity arterial disease in patients with 36 cases of acute thrombosis were analyzed, used YQHYR interventions, to observe the pre-clinical efficacy and intervention around the hind legs, hemorheology.Results: After the intervention cured 19 cases, markedly effective in 11 cases, effective in 5 cases, one case in invalid, the total effective rate was 97.22%; after intervention in patients with limb circumference of the ankle, shin and thigh circumference circumference were significantly higher than before the intervention reduction ( P〈0.05 ) .Conclusion: YQHYR interventions after endovascular treatment of lower extremity arterial disease with acute thrombosis, can improve the cure rate in patients, it is safe and effective.
作者 李孝虎
出处 《实用中医药杂志》 2014年第12期1077-1078,共2页 Journal of Practical Traditional Chinese Medicine
关键词 下肢动脉病变 腔内治疗 益气化瘀方 急性血栓形成 临床疗效 lower extremity arterial disease endovascular treatment YQHYR acute thrombosis clinical efficacy
  • 相关文献

参考文献6

二级参考文献30

  • 1谷涌泉,张建,齐立行,李建新,俞恒锡,李学锋,郭连瑞,崔世军,汪忠镐.下肢动脉支架与单纯球囊扩张成形治疗股浅动脉病变的对比性研究[J].中国血管外科杂志(电子版),2010,2(2):83-86. 被引量:2
  • 2王晓东,刘兴会.抗凝剂的种类及其在妊娠中的应用[J].中国实用妇科与产科杂志,2006,22(3):165-167. 被引量:40
  • 3万广珍,周生艳.高龄全髋关节置换术后下肢深静脉栓塞的预防[J].中国社区医师(医学专业),2006,8(17):106-106. 被引量:6
  • 4陈跃平,黄有荣,苏波,韩杰.人工髋关节置换术后下肢深静脉栓塞的预防[J].医学文选,2006,25(4):659-660. 被引量:4
  • 5王在谟.现代中药临床应用.第1版.北京:人民卫生出版社,2005:262.
  • 6乐杰.妇产科学[M].北京:人民卫生出版社,2002.416.
  • 7Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angio- plasty in severe ischaemia of the leg (BASIL) : Multicentre, randomised controlled trial. Lancet, 2005,366(9501) : 1925-1934.
  • 8Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society con- sensus for the management of peripheral arterial disease (TASC 11 ). J Vasc Surg, 2007,45(Suppl S) :S5-S67.
  • 9Siracuse JJ, Giles KA, Pomposelli FB, et al. Results for primary bypass versus primary angioplasty/stent for intermittent claudica- tion due to superficial femoral artery occlusive disease. J Vasc Surg, 2012,55(4) :1001-1007.
  • 10Bradbury AW, Adam DJ, Bell J, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients ran- domized to a bypass surgery-first or a balloon angioplasty-first re vascularization strategy. J Vasc Surgery, 2010,51(5 Suppl) : 5S- 17S.

共引文献21

同被引文献16

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部